L

Lincoln Park Capital, LLC

7 employees

Lincoln Park Capital Fund is a Chicago-based asset management firm focused on opportunistic investing in public and private companies.

Investor insights

Countries invested in

united states1

Sectors invested in

Biotechnology21
Health Care11
Pharmaceutical9
Medical7
Therapeutics7
Biopharma5
Wellness3
Artificial Intelligence3
Regenerative medicine2
Platelet and plasma-derived products2
Biodynamic hematogel2
Individualized wound care2
Clinical Trials2
Life Science2
Antigen Discovery1
contract manufacturing1
generic drugs1
extended release drug products1
Specialty Pharmaceuticals1
controlled release drug products1

Funding rounds participated in

$20M sweet spot round size

Most of their 27 investments are in rounds between $15M and $28M

Investor type

Private Equity Firm
Venture Capital

Basic info

Industry

investment banking

Sectors

Date founded

2010

Investments made

U

Undisclosed raised $30M on May 30, 2023

Investors: Lincoln Park Capital, LLC

M

Marker Therapeutics, Inc. raised $25M on December 13, 2022

Investors: Lincoln Park Capital, LLC

P

PaxMedica raised $20M on November 17, 2022

Investors: Lincoln Park Capital, LLC

D

DelMar Pharmaceuticals raised $20M on August 3, 2022

Investors: Lincoln Park Capital, LLC

E

Evaxion Biotech A/S raised $40M on June 7, 2022

Investors: Lincoln Park Capital, LLC

A

Aquestive Therapeutics raised $40M on April 13, 2022

Investors: Lincoln Park Capital, LLC

B

Biodesix, Inc. raised $50M on March 7, 2022

Investors: Lincoln Park Capital, LLC

G

GridIron BioNutrients raised $4M on November 30, 2021

Investors: L1 Capital and Lincoln Park Capital, LLC

O

Ocuphire Pharma raised $15M on June 8, 2021

Investors: Ayrton Capital, Altium Capital and Lincoln Park Capital, LLC

C

Cyclerion raised $18M on June 4, 2021

Investors: Slate Path Capital LP, The Invus Group, Polaris Partners and Lincoln Park Capital, LLC

FAQ